Aarti Drugs Ltd (BOM:524348)
₹ 480.2 6.1 (1.29%) Market Cap: 44.15 Bil Enterprise Value: 49.58 Bil PE Ratio: 24.85 PB Ratio: 3.31 GF Score: 91/100

Q2 2021 Aarti Drugs Ltd Earnings Call Transcript

Oct 26, 2020 / NTS GMT
Release Date Price: ₹711.35 (-4.99%)
Operator

Ladies and gentlemen, good day, and welcome to the Aarti Drugs Limited Q2 FY21 earnings conference call hosted by Centrum Broking Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Cyndrella Carvalho from Centrum Broking. Thank you, and over to you, ma'am.

Cyndrella Carvalho Centrum Broking Limited;Moderator;Adhish

Thanks, Faizan. Good afternoon, everyone. On behalf of Centrum Broking, I Cyndrella Carvalho, thank the Aarti Drugs management team for giving us this opportunity to host the Q2 earnings con call. From Aarti Drugs management team, we have today with us Mr. Harshit Savla, Joint Managing Director; Mr. Harit Shah, Whole-time Director; Mr. Adhish Patil, Chief Financial Officer; Mr. Vishwa Savla, Director, Pinnacle Life Sciences. At the outset, I congratulate the management team on continuing to deliver excellent earnings in these unprecedented times. I now hand over the call to Chief Financial Officer, Mr. Adhish Patil for their opening remarks. Over to you Adhish.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot